Growth Metrics

Bio-Techne (TECH) EPS (Weighted Average and Diluted) (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 33.33%
Dec 31, 2025 0.00%
Sep 30, 2025 318.18%
Jun 30, 2025 -178.57%
Mar 31, 2025 -36.36%
Dec 31, 2024 4.76%
Sep 30, 2024 -19.23%
Jun 30, 2024 -16.13%
Mar 31, 2024 82.35%
Dec 31, 2023 -45.16%
Sep 30, 2023 -32.61%
Jun 30, 2023 6.98%
Mar 31, 2023 38.71%
Dec 31, 2022 -43.64%
Sep 30, 2022 44.74%
Jun 30, 2022 2.70%
Mar 31, 2022 -24.49%
Dec 31, 2021 -71.01%
Sep 30, 2021 175.45%
Jun 30, 2021 -300.00%
Mar 31, 2021 -2.61%
Dec 31, 2020 38.55%
Sep 30, 2020 -43.92%
Jun 30, 2020 60.87%
Mar 31, 2020 -69.54%
Dec 31, 2019 716.22%
Sep 30, 2019 -11.90%
Jun 30, 2019 -63.48%
Mar 31, 2019 155.56%
Dec 31, 2018 0.00%
Sep 30, 2018 -57.94%
Jun 30, 2018 105.77%
Mar 31, 2018 -59.69%
Dec 31, 2017 207.14%
Sep 30, 2017 -43.24%
Jun 30, 2017 25.42%
Mar 31, 2017 195.00%
Dec 31, 2016 -60.00%
Sep 30, 2016 -27.54%
Jun 30, 2016 -14.81%
Mar 31, 2016 17.39%
Dec 31, 2015 13.11%
Sep 30, 2015 -12.86%
Jun 30, 2015 7.69%
Mar 31, 2015 -26.97%
Dec 31, 2014 39.06%
Sep 30, 2014 -12.33%
Jun 30, 2014 -14.12%
Mar 31, 2014 25.00%
Dec 31, 2013 -8.11%
Sep 30, 2013 -3.90%
Jun 30, 2013 -14.44%
Mar 31, 2013 30.43%
Dec 31, 2012 -1.43%
Sep 30, 2012 -5.41%
Jun 30, 2012 -13.95%
Mar 31, 2012 22.86%
Dec 31, 2011 -5.41%
Sep 30, 2011 -2.63%
Jun 30, 2011 -9.52%
Mar 31, 2011 18.31%
Dec 31, 2010 0.00%
Sep 30, 2010 2.90%
Jun 30, 2010 -20.69%
Mar 31, 2010 31.82%
Dec 31, 2009 -8.33%